These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients. Fatti LM; Scacchi M; Lavezzi E; Pecori Giraldi F; De Martin M; Toja P; Michailidis G; Stramba-Badiale M; Cavagnini F Clin Endocrinol (Oxf); 2006 Nov; 65(5):626-30. PubMed ID: 17054464 [TBL] [Abstract][Full Text] [Related]
9. [The heart in acromegaly: an echocardiographic study]. Kawanishi H; Suda K; Mori T; Chiba T; Matsuda Y; Inatome T; Inoh T; Yokota Y; Matsumoto K; Fukuzaki H J Cardiogr; 1984 Oct; 14(3):459-69. PubMed ID: 6242154 [TBL] [Abstract][Full Text] [Related]
10. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment. Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555 [TBL] [Abstract][Full Text] [Related]
11. [Standard electrocardiography and Holter monitoring changes in acromegalic patients]. Twardowski R; Dabek J; Jakubowski D; Gasior Z Pol Merkur Lekarski; 2007 Jun; 22(132):519-23. PubMed ID: 17874620 [TBL] [Abstract][Full Text] [Related]
12. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure? Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870 [TBL] [Abstract][Full Text] [Related]
13. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly. Lombardi G; Colao A; Marzullo P; Ferone D; Longobardi S; Esposito V; Merola B J Endocrinol; 1997 Oct; 155 Suppl 1():S33-7; discussion S39. PubMed ID: 9389993 [TBL] [Abstract][Full Text] [Related]
14. Growth hormone, body composition and somatomedin C after treatment of acromegaly. McLellan AR; Connell JM; Beastall GH; Teasdale G; Davies DL Q J Med; 1988 Dec; 69(260):997-1008. PubMed ID: 3270086 [TBL] [Abstract][Full Text] [Related]
15. [Role of arterial hypertension in the cardiac involvement of acromegaly]. Morvan D; Komajda M; Grimaldi A; Turpin G; Grosgogeat Y Arch Mal Coeur Vaiss; 1990 Sep; 83(10):1507-13. PubMed ID: 2146935 [TBL] [Abstract][Full Text] [Related]
16. Growth hormone, acromegaly, and heart failure: an intricate triangulation. Saccà L; Napoli R; Cittadini A Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906 [TBL] [Abstract][Full Text] [Related]
17. [The place of insulin-like growth factor I in the diagnosis of acromegaly]. Dohán O; Góth M; Szabolcs I; Kovács L; Kovács Z; Szilágyi G Orv Hetil; 1993 Oct; 134(42):2301-3. PubMed ID: 8233444 [TBL] [Abstract][Full Text] [Related]
18. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly. Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658 [TBL] [Abstract][Full Text] [Related]
19. Late potentials and ventricular arrhythmias in acromegaly. Maffei P; Martini C; Milanesi A; Corfini A; Mioni R; de Carlo E; Menegazzo C; Scanarini M; Vettor R; Federspil G; Sicolo N Int J Cardiol; 2005 Sep; 104(2):197-203. PubMed ID: 16168814 [TBL] [Abstract][Full Text] [Related]
20. Dynamic testing in the diagnosis and follow-up of patients with acromegaly. Wass JA J Endocrinol Invest; 2003; 26(7 Suppl):48-53. PubMed ID: 14604066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]